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An Unusually Broad series of seven 
Cyclombandakamines, Bridged 
Dimeric Naphthylisoquinoline 
Alkaloids from the Congolese Liana 
Ancistrocladus ealaensis
Dieudonné tshitenge tshitenge1,2, torsten Bruhn3, Doris Feineis1, Virima Mudogo4, 
Marcel Kaiser5,6, Reto Brun5,6 & Gerhard Bringmann1
A series of seven unusual dimeric naphthylisoquinoline alkaloids was isolated from the leaves of 
the tropical liana Ancistrocladus ealaensis J. Léonard, named cyclombandakamine A (1), 1-epi-
cyclombandakamine A (2), and cyclombandakamines A3–7 (3–7). These alkaloids have a chemically 
thrilling structural array consisting of a twisted dihydrofuran-cyclohexenone-isochromene system. 
The 1′″-epimer of 4, cyclombandakamine A1 (8), had previously been discovered in an unidentified 
Ancistrocladus species related to A. ealaensis. Both lianas produce the potential parent precursor, 
mbandakamine A (9), but only A. ealaensis synthesizes the corresponding cyclized form, along with a 
broad series of slightly modified analogs. The challenging isolation required, besides multi-dimensional 
chromatography, the use of a pentafluorophenyl stationary phase. Featuring up to six stereocenters 
and two types of chiral axes, their structures were elucidated by means of 1D and 2D NMR, HRESIMS, in 
combination with oxidative chemical degradation experiments as well as chiroptical (electronic circular 
dichroism spectroscopy) and quantum chemical calculations. Compared to the ‘open-chain’ parent 
compound 9, these dimers displayed rather moderate antiplasmodial activities.
The plant family Ancistrocladaceae – together with the related Dioncophyllaceae – has been in the focus 
of our most recent phytochemical investigations1–4. This interest is justified by the exclusive occurrence of 
polyketide-derived naphthylisoquinoline alkaloids in these plants5–8. The chemical thrill induced by their broad 
structural diversity2,9, unprecedented biosynthesis, and pronounced biological activities has made them most 
attractive natural products10–14.
After the isolation of mbandakamines A and B in an as yet botanically undescribed Congolese Ancistrocladus 
species9, our group has intensified the search for new secondary metabolites in Central African taxa3, in particu-
lar in those found in the region of Mbandaka (Democratic Republic of the Congo)15. In this framework, we have 
just reported the occurrence of cyclombandakamine A1 (8)16, in the same ‘new’ plant, and postulated that 8 could 
originate biosynthetically from an ‘open-chain’ N-methylated mbandakamine A precursor16. Unfortunately, the 
respective precursor to 8 was not found in that plant nor was the authentic cyclization product of 9, cyclombanda-
kamine A (1) – despite the high content of 9 in the leaves of the probably ‘new’ Ancistrocladus species.
In recent investigations on the botanically well-described liana Ancistrocladus ealaensis J. Léonard5, we have 
documented the occurrence of ealapasamines A-C17, michellamine-type and mbandakamine-like dimers18, 
and of a plethora of further, monomeric naphthylisoquinoline alkaloids18. These findings already suggested 
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an outstanding biosynthetic potential of the Central African liana A. ealaensis compared to other known 
Ancistrocladus species.
The systematic analysis of leaf extracts of A. ealaensis, which had already revealed the presence of three types 
of unsymmetric dimeric naphthylisoquinoline alkaloids17,18, showed that it was not unlikely to find further sin-
gularities. These investigations led to the isolation and purification of cyclombandakamine A (1), its 1-epimer 2, 
and five related dimeric alkaloids, 3–7, all featuring an unusual condensed cage-like polycyclic backbone (Fig. 1). 
Their structural elucidation is herein described, as well as their anti-infective profiles.
Figure 1. Cyclombandakamine A (1), 1-epi-cyclombandakamine A (2), and cyclombandakamines A3-A7 
(3–7) isolated from leaf material of A. ealaensis. Also depicted are the yet known cyclombandakamine A1 (8), 
mbandakamines A (9), C (10) and E (12), and cis-isoshinanolone (11).
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Results and Discussion
Isolation. The spectroscopy-guided analysis of a crude leaf extract of A. ealaensis by LC-DAD and LC-MS 
hinted at the presence of a new type of alkaloid, with unusual UV spectra and MS patterns typical of dimeric 
naphthylisoquinoline alkaloids. The leaf material was macerated with MeOH, and the extract was further 
exhaustively partitioned between water and dichloromethane. The organic phases were collected and submit-
ted to reversed-phase chromatography to obtain more slowly eluting subfractions, in which the hard-to-resolve 
cyclombandakamines were enriched. The isolation by semi-preparative HPLC – on different stationary materials 
– afforded seven such alkaloids in a pure form.
Structural elucidation of compounds 1–7. Cyclombandakamine A (1). Its resolution succeeded only 
on a silica-bonded High-Speed F5 column (having a pentafluorophenyl phase), showing a molecular formula of 
C48H50N2O8 and, thus, an Index of Hydrogenation Deficiency (IHD) of 25 as deduced by HRESIMS. This molec-
ular formula was identical to that of mbandakamine D18, but the UV and the ECD spectra, and the NMR data 
were significantly different, hinting at an unknown unsymmetric dimer with 48 non-equivalent carbon atoms. 
Most remarkable was the presence of seven – instead of eight – aromatic protons in the 1H-NMR spectrum, and 
of three unusual carbon signals in 13C NMR. Its demanding absolute stereostructure was elucidated by means of 
extensive 1D and 2D NMR experiments, ruthenium-mediated oxidative degradation, ECD spectroscopy, and 
DFT-based ECD spectra calculations (see also Supporting Information).
As in the case of 9, the ‘southeastern’ portion of the molecule showed four aromatic protons, but also two 
methoxy functions and seven further signals in the 1H NMR spectrum (Fig. 2). Data analysis revealed a tetrahy-
droisoquinoline subunit, which possessed one aromatic singlet at H-7 (δH,C 6.39, 98.6) interacting in HMBC 
with two oxygenated carbons, C-6 and C-8. The presence of an O-methyl group at C-8 was evidenced by ROESY 
interactions from H-7 and H-1 (δH,C 4.68, 49.7) to 8-OMe (δH 3.85), leaving the unprotonated C-5 (δC 119.7) as 
the coupling position. The typical two methyl doublets at C-1 and C-3, the signals of the two diastereotopic pro-
tons at C-4 (δH 1.94 and 2.35), and the multiplet at C-3 (δH,C 3.52, 44.9) were also detected as parts of this subunit 
(Fig. 2c). Its relative trans-configuration at C-1 vs. C-3 was assigned by the ROESY interaction from the doublet 
of 1-Me (δH 1.50) to the multiplet of H-3 (Fig. 2d).
Attached to this moiety was a two-fold oxygenated naphthalene unit possessing one pair of meta-coupled 
protons at C-1′ (δH,C 6.52, 118.0) and C-3′ (δH,C 6.79, 108.7), one aromatic proton singlet H-7′ (δH,C 6.35, 126.0), 
and signals for a methoxy function at C-4′ and a methyl group at C-2′. The presence of a proton singlet at C-7′ 
suggested that C-6′ and C-8′ were quaternary. This assumption was corroborated by two HMBC interactions 
with carbon atoms belonging to another spin system. The HMBC cross peak between H-7′ and C-5 indicated a 
5,8′-linkage to the tetrahydroisoquinoline unit (Fig. 2c,d). Additionally, H-7′ showed ROEs with 4-Heq (δH 2.35), 
while H-1′ exhibited cross-peaks in both dimensions with 4-Hax (δH 1.94), confirming the coupling site of the 
two subunits and, thus, establishing the relative overall configuration in this 5,8′-coupled portion, viz. 5P,1R,3R 
or 5M,1S,3S. The oxidative degradation following a procedure developed earlier19, established C-3 and C-3′″ to 
Figure 2. Parts of the (a) 1H- and (b) 13C-NMR spectra of cyclombandakamine A (1). Chemical shifts, selected 
ROESY (double blue arrows) and HMBC (single red arrows) interactions in the southeastern (c,d) and the 
northwestern (e,f) portions of 1.
4Scientific RepoRts |          (2019) 9:9812  | https://doi.org/10.1038/s41598-019-46336-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
be R-configured, from which the overall absolute configuration in this molecular half was deduced as 5P,1R,3R, 
like in 9.
The HMBC correlation from H-7′ to one of the uncommon signals, viz., at a resonance of δC 85.5 – located 
in the ‘northwestern’ portion – showed the necessity to elucidate its direct chemical environment. In addition to 
H-7′, a methyl group at δH,C 1.84 and 18.4 (2″-Me), two diastereotopic-proton doublets at δH 3.13 (3″-Hax) and 
3.03 (3″-Heq) exhibited 3JC,H-HMBC cross peaks with the same quaternary carbon at δC 85.5 (C-1″). One binding 
site of C-1″ remained undefined, but its low-field chemical shift suggested a linkage to an electronegative group, 
probably a heteroatom. The presence of the two diastereotopic protons at C-3″ (δC 52.2) was unprecedented and 
suggested its proximity to a stereocenter. The methyl group (singlet) attached to an aliphatic carbon C-2″ (δC 
92.4), showed exclusive HMBC interactions to C-1″, C-2″, and C-3″ (Fig. 2e,f). This indicated, on the one hand, 
the location of the methyl group to be between C-1″ and C-3″ and, on the other hand, revealed the lack of a pro-
ton at C-2″, which should be the additional quaternary carbon atom in this spin system. One substituent at C-2″ 
remained yet unclear at this point, but was well defined at a later stage of the structural analysis.
A carbonyl function was detected at C-4″ (δC 196.3) showing HMBC correlations with the diastereotopic 
protons 3′-Heq and 3′-Hax. An aromatic-proton doublet in the 1H spectrum displayed a 4JC,H-HMBC interaction 
to C-4″, hinting at the connection to a remote molecular fragment. This doublet (J = 9.0 Hz) at a resonance of δH 
7.35 was ortho-coupled to another one, but more deshielded, at δH 7.96. The ROESY interaction between a meth-
oxy group (5″-OMe, δH,C 3.96, 56.8) and H-6″ (δH,C 7.35, 113.9), and the HMBC correlation from H-7″ (δH,C 7.96, 
135.6) to C-5″ (δC 160.7) clarified the assignment in the aromatic system as depicted in Fig. 2e,f.
Moreover, 4JC,H-HMBC correlations from H-6″ and 3″-Heq to a quaternary carbon at the resonance of δC 
119.5 (C-10″), from H-7″ to C-9″ (δC 138.5), and the 4JC,H-HMBC cross peak observed from H-7″ to C-1″ 
unambiguously proved the presence of a tetralone substituent instead of a classical naphthalene moiety. 
In other Ancistrocladus species, such acetogenic tetralones – yet free, without an isoquinoline portion – like 
cis-isoshinanolone (11)20 were known to occur, but had never been found as part of a natural naphthylisoquino-
line alkaloid14.
This tetralone portion related to cis-isoshinanolone (11)21 showed a pair of ortho-coupled aromatic protons at 
H-6″ and H-7″, leaving C-8″ (δC 124.5) as the connecting point to another spin system. In the HMBC spectrum, 
an additional cross peak observed from H-7″ to a quaternary carbon at δC 119.2 (C-5′″) suggested the existence 
of a second linkage to the tetralone. One aromatic singlet at H-7′″ (δH,C 6.45, 102.7) displayed HMBC correlations 
with C-5′″, C-6′″ (δC 154.7), C-8′″ (δC 124.5), C-9′″ (δC 118.2), and C-1′″ (δC 46.6), reminiscent of a classical 
1,3-dimethyl-tetrahydroisoquinoline subunit as in the southeastern part of the dimer (Fig. 2d). The character-
istic quartet at C-1′″, the multiplet at C-3′″, and the doublets of doublets of the two diastereotopic protons at 
C-4′″, typical of a tetrahydroisoquinoline, were observed and assigned accordingly. By ROESY analysis, a relative 
trans-array of the two methyl groups was established in this moiety. The oxidative degradation revealed that all 
C-3 related positions were R-configured, thus leading to the assignment of a 1′″R,3′″R-tetrahydroisoquinoline, 
5′″,8″-coupled to a 5″-methoxy-2″-methyl tetralone unit, in this second portion (see Fig. 2e,f).
At this stage of the structural analysis, all signals detected in the 13C and 1H NMR spectra had been reliably 
assigned, and all the ten heteroatoms suggested by the molecular formula were positioned. Still, the calculated 
degree of unsaturation related to C48H50N2O8 was not yet reached, but, as yet, amounted to 23 instead of 25. This 
discrepancy by two units could only be explained by the formation of two additional, heterocyclic rings. As men-
tioned before, the resonance of the quaternary, and sp3-hybridized C-1″ suggested its connection to a heteroatom, 
and in this case, only an oxygen function attached to C-6′″ could explain its deshielded chemical shift at δC 85.5. 
This assumption was proven by the observed ROESY interactions from H-7″ to the two diastereotopic protons at 
C-4′″, proposing a quasi-coplanar orientation of the tetrahydroisoquinoline unit towards the substituted tetralone 
part, consecutive to the formation of a new pyran ring involving the oxygen function between C-6′″ and C-1″ 
(see Fig. 2f).
In the tetralone unit, the fourth bond of the quaternary C-2″ had so far remained undefined. Its very low-field 
shifted resonance at δC 92.4 hinted at a linkage to one of the neighboring oxygen functions, which in this case 
could only be the one at C-5′, consistent with its chemical shift. The ROESY correlations observed between 
4′-OMe and 2″-Me supported the presence of the resulting five-membered dihydrobenzofuran ring attached to 
the tetralone. By these investigations, the full constitution of the new dimer was established (Fig. 2e,f), displaying 
two oxygen-bridged heterocyclic rings, both unprecedentedly attached to a tetralone unit.
In contrast to the southeastern portion, the determination of the absolute configuration in the northwestern 
one turned out to be challenging because of the bridged chiral axis and the two additional stereogenic centers in 
the cyclohexenone ring, which could not be directly solved by oxidative degradation. However, the steric con-
straints imposed by the highly condensed ring systems enabled the discrimination between the possible ste-
reoisomers. As mentioned above, the formation of the pyran ring forced the – usually orthogonally oriented 
– isoquinoline to become nearly coplanar to the tetralone ‘plane’, with an angle of only 28.5°. This unprecedented 
orientation brought the axial and equatorial diastereotopic protons at C-4′″ in the vicinity of H-7″, as attested in 
the ROESY spectrum. However, a stronger ROE interaction of H-7″ to 4′″-Heq indicated that the bridged chiral 
axis between C-5′″ and C-8″ in this molecular half was P-configured.
Such a P-configured biaryl axis additionally implied that the oxygen bridge at C-1″ must have been formed 
from ‘above’ the tetralone plane, thus suggesting the absolute configuration at C-1″ to be R. In this molecular 
context, C-1″ would have to be S if the axis was M-configured, but that would not have been in agreement with 
the observed ROE interactions between H-7″ and 4′″-Heq, those from H-7 and H-7′ to 4′″-Hax, and those from 
3′″-Me to H-7 and H-7″. These data all strongly supported an R-configuration at C-1″.
The analysis of the DFT-calculated minimum structures (Fig. 3a–d) indicated that in the case of an 
R-configured C-2″ (Fig. 3a), the methyl 2″-Me should be under the ‘tetralone plane’, and thus, on the opposite 
side of the new bridge at C-1″, and would be expected to show long-range ROESY interactions to 4-Heq, given the 
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calculated distance of 3.269 Å – but no interaction to 4′-OMe should be possible. Additionally, these investiga-
tions predicted a decisive ROE interaction between 2″-Me and H-7′″, which was found to be corroborative for the 
relative trans-configuration in the tetralone, viz. 1″R,2″S or 1″S,2″R. With the known configuration at C-1″ (R), 
only a 1″R,2″S array was plausible for the cyclohexenone unit.
Moreover, the analysis of optimized structures featuring the relative cis-configuration, i.e. 1″R,2″R or 1″S,2″S, 
indicated that 2″-Me and H-7′″ showed opposite spatial orientations and should not exhibit cross peaks in the 
ROESY investigations. Thus, the absolute configuration at C-2″ was confirmed to be S (Fig. 3d).
Based on the aforementioned assignment, the full stereochemical array of the dimer 1 could only be 
5P,1R,3R,1″R,2″S,8″P,1′″R,3′″R as shown in Figs 1 and 3d. Additionally, the structural attributions agreed with 
the observed ROESY interactions across the two molecular halves, in particular those between H-7 and H-1′″, 
H-7′ and H-1′″, H-3 and 4′″-Hax, and from 3′″-Me to 8-OMe.
Additional proof was provided by time-dependent density functional theory (TDDFT) calculations of the 
ECD spectra, performed with TDCAM-B3LYP/def2-TZVP (Fig. 3e,f)16. The two relevant diastereomers fea-
turing a cis- (1″S,2″R,8″M) and a trans-configured (1″R,2″S,8″P) cyclohexenone were analyzed as previously 
described16. As anticipated, the experimental and the calculated ECD spectra for the trans-diastereomer of 1 
showed a good agreement, while the cis-diastereomer (1″S,2″R,8″M) displayed an opposite ECD curve, confirm-
ing the assignment established above. Due to its structural array reminiscent of the known – and co-occurring 
– ‘open-chain’ dimer mbandakamine A (9), the new compound 1 was named cyclombandakamine A.
1-epi-Cyclombandakamine A (2). Another compound, showing the same UV spectrum and the same molecular 
formula by HRESIMS as cyclombandakamine A (1), was also purified on a preparative HS F5 HPLC column. 
The structural data analysis (see Supporting Information) led to a constitution identical to that of 1. The typical 
seven aromatic protons, the two unusual doublets corresponding to two diastereotopic protons at C-3″, and the 
characteristic carbon signals at δC 196.3, 92.4, and 85.4 ppm were clearly visible. The singularity of compound 2 as 
compared to cyclombandakamine A (1) was its relative cis-configuration – instead of trans as in 1 – between C-1 
and C-3 as evidenced by the ROE interaction between H-1 (δH,C 4.52, 52.0) and H-3 (δH,C 3.09, 50.6). Moreover, 
the deshielded shift of C-3 and the shielded value of H-1 were in agreement with the ROE-based attribution. 
This alkaloid indicated no further dissimilarities to 1, thus leading to the elucidation of its structure as being 
Figure 3. (a–d) Minimum structures (calculated at the DFT-B3LYP-D3/def2-TZVP level) of the four most 
plausible stereoisomers of cyclombandakamine A (1), with the given absolute configurations and the expected 
crucial ROEs for the relative configuration. The ROESY interactions in blue are indicative of the trans- or cis-
orientation in the cyclohexanone while those in red are not expected to be observed. The green double arrows 
suggest the strongest ROEs between H-7″ and one of the diastereotopic protons at C-4′″, relevant for the axial 
configuration. (e) and (f) The experimental ECD spectrum of 1 compared to the curves calculated for the 
two most plausible trans-diastereomers (1″S,2″R and 1″R,2″S) in the tetralone subunit16, confirming that the 
isolated structure of 1 is the one shown in (d). The ECD spectra were calculated at the TDCAM-B3LYP/def2-
TZVP level16.
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1-epi-cyclombandakamine A (2), which could also be addressed as cyclombandakamine C based on the fact that 
its potential precursor – mbandakamine C (10)18 – had been found in A. ealaensis, too.
Cyclombandakamine A3 (3). Semi-preparative resolution on a Chromolith® column enabled the purification of 
a trace alkaloid, which, astonishingly, showed the same UV spectrum, the same molecular formula by HRESIMS, 
and the same constitution by NMR as 1 and 2 (see Supporting Information). The southeastern portion was ste-
reochemically identical to the one described for 1, and, thus, clearly different from that of 2. In the northwestern 
portion, ROESY interactions between H-1′″ (δH,C 4.49, 52.9) and H-3′″ (δH,C 3.81, 50.2) evidenced their diaxial 
orientation, from which a relative cis-configuration was attributed. Therefore, the only difference to cyclom-
bandakamine A (1) was the absolute configuration at C-1′″, being S-configured. This structural difference was 
also in agreement with a new ROESY cross-peak between 1′″-Me (δH,C 1.63, 20.4) and H-7 (δH,C 6.39, 98.6), while 
no ROE interactions were monitored between H-7 and H-1′″. The new alkaloid 3 was named cyclombanda-
kamine A3 (3), but it might also be addressed as 1′″-epi-cyclombandakamine A.
Cyclombandakamine A4 (4). In the same fraction from which 3 was isolated, the main chromatographic peak 
eluting more slowly on Chromolith® led to a molecular formula of C49H52N2O8 by HRESIMS, suggesting the pres-
ence of an additionally methylated analog of 1. Extensive structural data indicated strong similarities to cyclom-
bandakamine A, evidenced by all the so far typical signals in the NMR spectra (Fig. 2a,b, and Table 1). While 
no difference was noticed compared to 1 in the southeastern part, the new alkaloid 4 showed an additionally 
N-methylated tetrahydroisoquinoline subunit instead. This was evidenced by a singlet at a resonance of 3.03 ppm, 
corresponding to a methyl group on the nitrogen (2′″-NMe, δC 49.3). Moreover, the 1H- and 13C NMR shifts at 
C-1′″ (δH,C 5.04, 71.3) and C-3′″ (δH,C 4.46, 63.3) were extremely deshielded, hinting at a relative cis-configuration 
in this N-methylated subunit, as known from mbandakamine E (12)18. ROESY interactions from the low-field 
shifted quartet of H-1′″ to the unusual multiplet H-3′″ confirmed this relative configuration. Its stereochemically 
assigned elements of chirality – 5 P,1 R,3 R,1″R,2″S,8″P,1′″S,3′″R – were in line with the observed ROESY inter-
actions across the molecular halves, namely between 2′″-NMe and H-7 (δH,C 6.39, 98.4), and those from 8-OMe 
(δH,C 3.88, 56.3) to 2′″-NMe. The new alkaloid was named cyclombandakamine A4 (4).
Cyclombandakamine A5 (5). Along with compound 2, a fifth alkaloid purified on Symmetry® was obtained 
featuring the aforementioned characteristics of cyclized mbandakamines. High-resolution ESIMS and full NMR 
data analysis led to a constitution identical to that of 4 (C49H52N2O8). The main difference to 4 was found in the 
southeastern half, which again turned out to be cis-configured. This was evidenced by the ROESY interactions 
from H-1 (δH,C 4.53, 52.0) to H-3 (δH,C 3.09, 50.6), and their remarkable chemical shifts (see Fig. 4). The observed 
typical deshielded resonances of C-1′″ (δH,C 5.03, 71.4) and C-3′″ (δH,C 4.40, 63.0) may from now on be considered 
as characteristic of cis-configured and N-methylated (N-Me) tetrahydroisoquinolines located in the northwestern 
part of mbandakamines and cyclombandakamines. The new alkaloid 5 was named cyclombandakamine A5 (5). 
This dimer was the first unsymmetric naphthylisoquinoline alkaloid featuring one N-H and one N-Me tetrahy-
droisoquinoline subunit that were both cis-configured (see also Table 1).
Cyclombandakamine A6 (6). Eluting on LC after the fraction mainly containing 5, another better resolvable peak 
from the series displayed related UV (see Fig. 4e) and ECD spectra. Its molecular formula by HRESIMS corre-
sponded to C48H48N2O8, with an IHD of 26. Combined with the presence of only three proton doublets – with 
J ≈ 6.5 Hz – in the 1H high-field region and a deshielded 13C of signal at δC 175.2 (C-1), its constitution suggested the 
presence of a dihydroisoquinoline derivative of cyclombandakamine A (1). The resonance of the unprotonated C-1 
and the methyl singlet attached to it, 1-Me (δH,C 2.71, 24.9), were consistent with this assignment in the southeastern 
portion. Despite some minor chemical-shift variations, the rest of this molecular half was found to be identical to 
that of 1, including the absolute configurations. The new dimeric alkaloid was named cyclombandakamine A6 (6).
Cyclombandakamine A7 (7). Compound 7 required multidimensional-purification liquid chromatography to 
afford sufficient material for full characterization. From the data, all the common UV and ECD spectra, MS and 
NMR characteristics of a cyclized mbandakamine were observed at first glimpse. Its molecular formula was deduced 
to be C49H50N2O8, with an IHD of 26. The data analysis indicated its structural similarity to cyclombandakamine 
A5 (5), the main difference lying in the southeastern portion. In this molecular part, a dihydroisoquinoline subunit 
was identified, similar to the one found in 6. The assignment was proven by the resonance of the sp2-hybridized C-1 
(δC 175.4) in the 13C spectra and the presence of three methyl doublets in the high-field region of the 1H spectrum. 
Thus, the compound displayed a dihydroisoquinoline unit in the southeastern half and a relative cis-configured 
N-methyl tetrahydroisoquinoline sub-portion in the northwestern part. It was named cyclombandakamine A7 (7).
The isolation of such a large series of dimeric alkaloids was of high value and provided valuable insight into 
this unique class of natural products16. Even though the ‘central’ 6′,1″-C,C-linkage was no longer a chiral axis 
in these O-bridged dimers, an origin of 1 from 9 seemed most probable, based on our previous biosynthetic 
assumption on the origin of 816. The driving force for such an oxidative conversion of 9 to 1 might be the prox-
imity of the present chromophores and the gain of stability by the reduction of the steric load at the central axis, 
in particular at C-1″. Moreover, the orientations of the HO-5′ and HO-6′″ functions on opposite sides of the 
plane formed by the C-1″-substituted naphthalene unit in mbandakamine A (9) were favorable for the cycli-
zation, which should lead to trans-configured 5″-methoxy-2″-methyl-tetralone and, specifically, to the discov-
ered 1″R,2″S,8″P diastereomer only. This also meant that its atropo-diastereomer mbandakamine B, with its 
6′M,8″P biaryl axes should give the cis-configured cyclic diastereomer, viz. 1″R,2″R,8″P, exclusively. Interestingly, 
no such mbandakamine-B-derived cyclombandakamines have so far been found, nor any with a configuration at 
C-1″/C-2″ different from R,S.
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Position
1 2 3 4 5 6 7
δH (Hz) δC, type δC, type δC, type δC, type δH (Hz) δC, type δC, type δC, type
1 4.68, q 49.7, CH 52.0, CH 49.0, CH 49.1, CH 4.53, q 52.0, CH 175.2, C 175.4, C
3 3.52, m 44.9, CH 50.6, CH 44.8, CH 44.9, CH 3.09, m 50.6, CH 48.8, CH 48.8, CH
4
2.35, dd 32.7, CHeq 32.9, CHeq 32.8, CHeq 32.8, CHeq 2.17, dd 33.0, CHeq 32.6, CHeq 32.6, CHeq
1.94, dd 32.7, CHax 32.9, CHax 32.8, CHax 32.8, CHax 2.05, dd 33.0, CHax 32.6, CHax 32.6, CHax
5 119.7, C 119.9, C 119.8, C 120.0, C 120.0, C 122.2, C 122.2, C
6 157.5, C 156.5, C 157.6, C 157.1, C 157.0, C 167.4, C 167.2, C
7 6.39, s 98.6, CH 98.6, CH 98.6, CH 98.4, CH 6.39, s 99.1, CH 99.3, CH 99.0, CH
8 157.5, C 158.5, C 157.5, C 157.7, C 158.6, C 165.6, C 165.7, C
9 113.9, C 113.9, C 114.2, C 114.3, C 114.2, C 108.2, C 108.5, C
10 133.0, C 135.1, C 133.1, C 133.6, C 133.6, C 142.7, C 143.0, C
1′ 6.52, s 118.0, CH 118.1, CH 118.0, CH 117.9, CH 6.55, s 118.1, CH 117.7, CH 117.6, CH
2′ 139.6, C 139.6, C 139.6, C 139.8, C 139.8, C 140.1, C 140.1, C
3′ 6.79, s 108.7, CH 108.7, CH 108.7, CH 108.8, CH 6.81, s 108.7, CH 108.8, CH 108.9, CH
4′ 158.5, C 158.5, C 158.5, C 158.5, C 158.5, C 158.5, C 158.5, C
5′ 156.4, C 156.4, C 156.4, C 156.6, C 156.6, C 156.8, C 157.0, C
6′ 121.1, C 121.2, C 121.2, C 121.0, C 121.0, C 121.1, C 121.0, C
7′ 6.35, s 126.0, CH 126.3, CH 126.1, CH 126.0, CH 6.37, s 126.2, CH 126.0, CH 125.9, CH
8′ 126.6, C 126.3, C 126.5, C 126.6, C 126.1, C 124.9, C 124.7, C
9′ 138.7, C 139.0, C 138.4, C 138.7, C 139.0, C 138.5, C 138.5, C
10′ 114.3, C 114.4, C 114.3, C 114.4, C 114.5, C 114.3, C 114.3, C
1-Me 1.50, d 18.8, Me 20.2, Me 18.8, Me 18.8, Me 1.69, d 20.2, Me 24.9, Me 25.0, Me
3-Me 1.08, d 19.2, Me 18.6, Me 19.3, Me 19.1, Me 1.09, d 14.8, Me 17.8, Me 17.8, Me
2′-Me 2.28, s 22.5, Me 22.6, Me 22.5, Me 22.5, Me 2.30, s 22.6, Me 22.5, Me 22.5, Me
8-OMe 3.85, s 56.2, Me 56.0, Me 56.2, Me 56.3, Me 3.86, s 56.2, Me 56.9, Me 57.0, Me
4′-OMe 4.00, s 56.6, Me 56.6, Me 56.6, Me 56.6, Me 4.00, s 56.6, Me 56.6, Me 56.6, Me
1′″ 4.56, q 46.6, CH 46.6, CH 52.9, CH 71.3, CH 5.03, q 71.4, CH 46.6, CH 71.3, CH
3′″ 3.91, m 48.1, CH 48.1, CH 50.2, CH 63.3, CH 4.40, m 63.0, CH 48.1, CH 63.3, CH
4′″
3.68, dd 33.5, CHeq 33.6, CHeq 33.2, CHeq 33.5, CHeq 4.42, dd 34.9, CHeq 33.5, CHeq 34.7, CHeq
3.05, dd 33.5, CHax 33.6, CHax 33.2, CHax 33.5, CHax 2.90, dd 34.9, CHax 33.5, CHax 34.7, CHax
5′″ 119.2, C 118.9, C 119.3, C 117.7, C 117.4, C 119.1, C 117.6, C
6′″ 154.7, C 154.7, C 154.7, C 155.7, C 155.5, C 154.7, C 155.5, C
7′″ 6.45, s 102.7, CH 102.6, CH 102.4, CH 102.7, CH 6.46, s 102.7, CH 102.6, CH 102.7, CH
8′″ 158.6, C 158.6, C 158.6, C 158.0, C 158.0, C 158.5, C 158.0, C
9′″ 118.2, C 118.3, C 118.9, C 119.2, C 119.8, C 118.3, C 119.8, C
10′″ 128.7, C 128.7, C 131.0, C 127.9, C 128.1, C 128.8, C 128.2, C
1″ 85.5, C 85.4, C 85.3, C 85.4, C 85.4, C 85.3, C 85.4, C
2″ 92.4, C 92.4, C 92.4, C 92.5, C 92.4, C 92.5, C 92.5, C
3″
3.13, dd 52.2, CHeq 52.2, CHeq 52.3, CHeq 52.0, CHeq 3.13, dd 52.0, CHeq 52.2, CHeq 51.9, CHeq
3.03, dd 52.2, CHax 52.2, CHax 52.3, CHax 52.0, CHax 3.02, dd 52.0, CHax 52.2, CHax 51.9, CHax
4″ 196.3, CO 196.3, CO 196.3, CO 196.2, CO 196.2, CO 196.2, CO 196.1, CO
5″ 160.7, C 160.5, C 160.6, C 160.8, C 160.8, C 160.7, C 160.8, C
6″ 7.35, d 113.9, CH 113.9, CH 113.8, CH 114.0, CH 7.34, d 114.0, CH 114.0, CH 114.0, CH
7″ 7.96, d 135.6, CH 135.5, CH 135.6, CH 135.1, CH 8.32, d 135.1, CH 135.6, CH 135.2, CH
8″ 124.5, C 124.5, C 125.2, C 124.6, C 124.6, C 124.5, C 124.7, C
9″ 138.5, C 138.3, C 138.7, C 138.8, C 138.8, C 138.3, C 138.8, C
10″ 119.5, C 119.6, C 119.5, C 119.4, C 119.5, C 119.5, C 119.4, C
1′″-Me 1.67, d 20.2, Me 20.2, Me 20.4, Me 16.5, Me 1.78, d 16.5, Me 20.3, Me 16.5, Me
3′″-Me 0.72, d 14.9, Me 14.9, Me 14.6, Me 14.8, Me 1.50, d 18.6, Me 14.6, Me 14.8, Me
2″-Me 1.84, s 18.4, Me 18.4, Me 18.4, Me 18.3, Me 1.83, s 18.3, Me 18.3, Me 18.3, Me
8′″-OMe 3.72, s 56.5, Me 56.5, Me 56.4, Me 56.7, Me 3.73, s 56.7, Me 56.5, Me 56.8, Me
5″-OMe 3.96, s 56.8, Me 56.8, Me 56.8, Me 56.8, Me 3.96, s 56.8, Me 56.8, Me 56.8, Me
2′″-NMe 49.3, Me 3.11 49.3, Me 49.5, Me
Table 1. 1H (600 MHz) and 13C (151 MHz) data of the cyclombandakamines 1–7 in methanol-d4.
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The bicyclic ring system of cis-isoshinanolone (11)7,20–22, a natural tetralone derivative likewise occurring in 
Congolese Ancistrocladus lianas, is a characteristic structural motive in the cyclombandakamines. In the case 
of the dimers reported here, only the cis-form of this tetralone – with its OH and Me residues on the same side 
– would be favorable to provide, via a probably enzymatic cyclization, the diastereomer found in the isolated 
dimeric alkaloids. This formation of the cyclic compounds may be supported by the co-occurrence of 1 and 2 
together with their open-chain analogs 9 and 10 in A. ealaensis.
The long-known sensitivity of cis-configured naphthylisoquinolines, if devoid of an N-methyl group (N-H), 
to oxidation23 showed that their successful isolation here was an indication of mild workup procedures. Since 
cyclombandakamines were likely to be oxidation products from ‘open-chain’ mbandakamine-like alkaloids16, the 
discovery of such dimers with intact N-H cis-relative configurations were a further argument against an imagina-
ble spontaneous, non-enzymatic oxidative formation, but rather hinted at a strictly regulated enzymatic process 
for their biosynthesis in A. ealaensis, evidencing that the compounds were true natural scaffolds and no artificial 
follow-up products from their analogs.
The similarity of the ECD spectra, despite the different variations in the isoquinoline moieties, further 
proved the reported16 chiroptical dominance of the twisted dihydrofuran-tetralone-pyran chromophore towards 
the other present elements of chirality. A remarkable structural feature of these dimers is the co-occurrence of 
bridged and non-bridged biaryl axes, which was quite unique among dimeric naphthylisoquinoline alkaloids. 
The isolation of this series of novel compounds indicated once more the impressive biosynthetic potential of the 
tropical liana A. ealaensis.
Biological evaluations. In contrast to the corresponding open-chain mbandakamines, the cyclom-
bandakamines exhibited in vitro activities in the low micromolar range against the chloroquine sensitive 
(NF54) and resistant (K1) strains of P. falciparum, the causative agent of malaria. Cyclombandakamine A (1), 
1-epi-cyclombandakamine A (2), cyclombandakamine A5 (5), and cyclombandakamine A6 (6) showed IC50 values 
of 0.664 (NF54) and 0.268 µM (K1), 0.300 (NF54) and 0.148 µM (K1), n.d. (NF54) and 0.350 µM (K1), and 0.666 
(NF54) and 0.266 µM (K1), respectively (Table 2). These four alkaloids featured the structural variations observed 
within this series of dimers. Interestingly, they were found to be more active against the chloroquine-resistant 
strain K1 than against the sensitive strain NF54. The lower activities of 1 and 2 compared to their open-chain 
Figure 4. Chemical shifts (in ppm) of (a) the southeastern and (c) the northwestern halves of 5. Selected 
ROESY (double blue arrows) and HMBC (single red arrows) interactions in (b) the first and in (d) the second 
halves of cyclombandakamine A5 (5). (e) Typical UV spectra of cyclombandakamine alkaloids.
9Scientific RepoRts |          (2019) 9:9812  | https://doi.org/10.1038/s41598-019-46336-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
analogs suggested that the highly condensed polycyclic system or the reduced number of free phenolic OH 
groups might be decisive for the reduced anti-infective potential of cyclombandakamines. Against Trypanosoma 
brucei rhodesiense, T. cruzi, and Leishmania donovani, very low (in the case of 1 and 2 for T. b. rhodesiense) or 
virtually no activities were found for any of the evaluated cyclombandakamines. This finding confirms the distinct 
structure dependency – and thus high specificity – of the antiplasmodial activities of the dimeric naphthyliso-
quinoline alkaloids presented in Table 2.
In conclusion, the cyclized mbandakamines displayed a weaker anti-infective potential as compared to the 
related open-chain alkaloids. While the role of these compounds for the plants and the details of their biosyn-
thetic formation need to be further explored, their charm lies in their intriguing, unprecedented structures.
Experimental Section
General experimental procedures. A Jasco® LC-2000Plus Series System (Gross-Umstadt, Germany) was 
used for LC-DAD analysis. LC-MS measurements were performed on an Agilent 1100 Series System, equipped 
with binary high-pressure mixing pumps, with an autosampler, a degasser module, a 1100 series photodiode array 
(PDA) detector (Agilent Technology, Germany), and an ion-trap mass spectrometer with an electrospray ioni-
zation interface (Bruker Daltonics, Bremen, Germany). A Bruker Daltonics microTOF spectrometer focus was 
used for high-resolution electrospray mass spectrometry (positive mode). NMR analyses were acquired on AMX 
400 and DMX 600 Bruker spectrometers with cryoprobes. The offline ECD and ORD spectra were recorded on a 
Jasco J-715 spectropolarimeter, and evaluated with SpecDis_16424,25. A Shimadzu UV-1800 spectrophotometer 
was used to perform offline UV measurements in triplicate. A Jasco P-1020-polarimeter operating with a sodium 
light source (λ = 589 nm) was used for the measurement of optical rotations. The mechanical shaker operating at 
the frequency of 160 RPM (rotations per minutes) was from Bottmingen (Switzerland).
plant material. Leaf material of Ancistrocladus ealaensis5,17 was collected in Mbandaka, at the Botanical 
Garden of Eala (Democratic Republic of the Congo), in August 2008 by one of us (V.M.) and in August 2015 by 
Mr. B.K. Lombe (GPS coordinates 00°03.605N, 018°18.886E). The material of 2015 was additionally authenti-
cated by LC-DAD-MS to contain the same metabolites as the one of 2008. Voucher specimens are available at the 
Herbarium Bringmann at the Institute of Organic Chemistry, University of Würzburg (nos. 43 and 57).
Extraction and isolation. The air-dried leaf material (800 g) was macerated for 24 h in MeOH, with 
mechanical shaking (160 RPM), followed by further macerations until exhaustion. The 24-h macerates were 
mixed, filtered, and evaporated to give a viscous solution. The methanolic extract was dissolved in water to permit 
precipitation of chlorophyll. The partition of the aqueous solution was cleared from residual undesired material 
using n-hexane, before being exhaustively extracted with CH2Cl2. The organic layer was evaporated to dryness to 
obtain fraction A. This dichloromethane phase collected under neutral conditions (pH 7) was likewise dissolved 
in MeOH and submitted to reversed-phase chromatography, which led to the more slowly eluting subfractions 
A83-A96. The elution was performed from 0 to 50% H2O in MeCN. Subfractions enriched with cyclombanda-
kamines, but still present as hardly resolvable mixtures, were subjected to a multi-dimensional isolation proce-
dure using semi-preparative HPLC to afford the alkaloids in a pure form.
Isolation and semi-preparative HPLC conditions. For this purpose, four gradient elution conditions 
were used:
System 1. Isolation was performed on a Symmetry® Prep-C18 column (Waters, 300 × 19 mm, 7 μm), using A 
(H2O, 0.05% TFA) and B (MeCN, 0.05% TFA), with a flow rate of 10 mL min−1. The gradient details were as 
described for the isolation of the ealapasamines A-C17 to afford the enriched fractions.
System 2. Purification was performed on a Discovery® HS F5–10 column (Supelco®, 250 × 21.2 mm, 10 μm), 
using A (H2O, 0.05% TFA) and B (MeCN, 0.05% TFA), with a flow rate of 13 mL min−1. The stationary phase was 
pentafluorophenyl-bonded high-speed silica, which offers different separations processes on C18, characterized 










Standard 0.01[1] 3.56[2] 0.43[3] 0.01[4]/0.36[4] n.d.
1 12.38 63.80 39.55 0.664/0.268 67/166
2 6.36 58.31 >127.73 0.300/0.148 >61/117
5 — — — −/0.350 −/52
6 50.22 95.79 >127.73 0.666/0.266 138/346
9 1.8 16.8 >100 0.06/− 277/−
10 1.8 41.8 >100 0.05/0.06 337/249
Table 2. Biological evaluations of 1, 2, 5, and 6 against Plasmodium falciparum (strains: NF54 and K1), 
Trypanosoma brucei rhodesiense, T. cruzi, and Leishmania donovani. The cytotoxicities of the compounds 
were determined against rat skeletal myoblasts (L6 cells). [1] Melarsoprol. [2] Benznidazole. [3] Miltefosine. 
[4] Chloroquine. All IC50 values are given in µM. n.d.: not determined. Selectivity index determined for P. 
falciparum.
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33 min: 70% of B, 48 min: 75% of B, 50 min: 100% of B, yielding 12.3 mg of cyclombandakamine A (1) and 6.1 mg 
of 1-epi-cyclombandakamine A (2), eluting faster than 9 and 10.
System 3. Further purification was achieved using a Chromolith® SemiPrep RP-18e column (100 × 10 mm), and 
a mobile phase made of A and C (MeOH, 0.05% TFA), at the flow rate of 14.2 mL min−1. The gradient used was: 
0–6 min: 5% of C, 11–15 min: 30% of C, 15.1–25 min: 33% of C, 26 min: 40% of C, 27 min: 45% of C, 28 min: 100% 
of C, to yield 5.5 mg of cyclombandakamine A5 (5), 11.3 mg of cyclombandakamine A6 (6), 2.5 mg of cyclom-
bandakamine A7 (7), along with other related compounds, which were not fully characterized.
System 4. Further purification was performed on a Chromolith® SemiPrep RP-18e column using the mobile 
solvent systems A and C (MeOH, 0.05% TFA), at the flow rate of 10 mL min−1. The gradient used was: 0–2 min: 
5% of C, 13–28 min: 30–50% of C, 29 min: 100% of C, yielding 1.5 mg of cyclombandakamine A3 (3), 4.6 mg of 
cyclombandakamine A4 (4), along with 0.5 mg of cyclombandakamine A5 (5).
Cyclombandakamine A (1). White amorphous powder; α[ ]D
23− 22 (c = 0.1, MeOH); UV (MeOH) λmax (log 
ε) = 201 (1.88), 216 (1.30), 233 (1.52), 257 (0.50), 277 (0.28), 288 (0.28), 295 (0.28), 315 (0.34), 330 (0.24), 340 
(0.19), 385 (0.03) nm; ECD (MeOH, c 0.3) λmax (log ε in cm2 mol−1) 200 (+8.48), 207 (‒5.19), 216 (+7.68), 219 
(+6.55), 233 (+32.09), 247 (‒21.84), 287 (+3.07), 304 (‒10.12), 325 (+4.15), 347 (‒0.26), 360 (+1.82), 400 
(+0.04) nm; ORD (MeOH, c 0.3) λmax (log ε in cm2 mol−1) 201 (+6.27), 211 (‒9.54), 217 (‒4.22), 224 (‒8.70), 239 
(+40.49), 269 (‒7.00), 295 (+6.09), 315 (‒9.28), 340 (+0.07), 353 (‒1.91), 386 (+0.65), 430 (+0.22) nm; 1H NMR 
and 13C NMR data: see Table 1 (for further details, see SI); HRESIMS m/z 783.36451 [M + H]+ (calcd for 
C48H51N2O8, 783.36399).
1-epi-Cyclombandakamine A (2). White amorphous powder; α[ ]D
23 − 21 (c 0.1, MeOH); UV (MeOH) λmax (log 
ε) 201 (1.88), 216 (1.32), 233 (1.49), 257 (0.50), 277 (0.28), 288 (0.28), 295 (0.28), 315 (0.34), 330 (0.24), 340 
(0.19), 385 (0.03) nm; ECD (MeOH, c 0.3) λmax (log ε in cm2 mol−1) 200 (+8.48), 206 (‒5.20), 216 (+7.68), 218 
(+6.54), 233 (+32.10), 247 (‒21.80), 287 (+3.09), 304 (‒11.10), 325 (+4.15), 347 (‒0.26), 360 (+1.82), 400 
(+0.01) nm; ORD (MeOH, c 0.3) λmax (log ε in cm2 mol−1) 201 (+6.30), 211 (‒9.50), 218 (‒4.22), 224 (‒8.70), 239 
(+39.49), 269 (‒7.05), 295 (+6.09), 315 (‒9.28), 340 (+0.08), 353 (‒1.91), 386 (+0.65), 400 (+0.30) nm; 13C NMR 
data in Table 1 (for further details, see SI); HRESIMS m/z 783.36229 [M + H]+ (calcd for C48H51N2O8, 783.36451). 
It can also be addressed as cyclombandakamine C.
Cyclombandakamine A3 (3). White amorphous powder; α[ ]D
23 − 13 (c 0.04, MeOH); UV (MeOH) λmax (log ε) 201 
(1.88), 216 (1.30), 233 (1.52), 257 (0.50), 277 (0.28), 288 (0.285), 295 (0.28), 315 (0.34), 330 (0.24), 340 (0.19), 390 
(0.02) nm; ECD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 200 (+2.23), 210 (+0.41), 212 (+0.49), 220 (‒0.44), 234 
(+4.66), 251 (‒2.99), 286 (+0.29), 304 (‒1.57), 328 (+0.43), 347 (‒0.03), 354 (+0.20), 365 (+0.27), 400 (‒0.01) 
nm; ORD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 201 (+3.13), 211 (‒4.94), 217 (‒2.12), 224 (‒4.44), 240 
(+19.23), 269 (‒3.45), 294 (+3.05), 314 (‒5.00), 340 (+0.02), 355 (‒0.89), 388 (+0.35), 430 (+0.10) nm; 13C NMR 
data in Table 1 (for further details, see SI); HRESIMS m/z 783.36203 [M + H]+ (calcd for C48H51N2O8, 783.36399).
Cyclombandakamine A4 (4). White amorphous powder; α[ ]D
23 − 14 (c 0.04, MeOH); UV (MeOH) λmax (log ε) 205 
(1.11), 217 (0.70), 230 (1.01), 257 (0.24), 262 (0.25), 297 (0.14), 315 (0.15), 322 (0.21), 329 (0.19), 338 (0.25), 344 
(0.29) nm; ECD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 200 (+2.25), 205 (+0.72), 213 (‒2.74), 220 (+2.16), 232 
(+7.16), 248 (‒5.94), 287 (+0.05), 304 (‒3.18), 325 (+0.68), 347 (‒0.59), 360 (+0.34), 385 (‒0.12), 400 (‒0.31) 
nm; ORD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 202 (‒0.35), 209 (‒1.79), 217 (‒0.13), 224 (‒0.92), 240 
(+10.15), 269 (‒1.31), 295 (+1.59), 316 (‒2.57), 341 (‒0.13), 353 (‒0.94), 382 (+0.09), 393 (+0.14), 460 (‒0.23) 
nm; 13C NMR data in Table 1 (for further details, see SI); HRESIMS m/z 813.37506 [M + H + O]+ (calcd for 
C49H53N2O9, 813.37511). The molecular formula is C49H52N2O8.
Cyclombandakamine A5 (5). White amorphous powder; α[ ]D
23 + 18 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 201 
(1.88), 216 (1.32), 233 (1.49), 257 (0.50), 277 (0.28), 288 (0.28), 295 (0.28), 315 (0.34), 330 (0.24), 340 (0.19), 385 
(0.03) nm; ECD (MeOH, c 0.2) λmax (log ε in cm2 mol−1) 202 (+7.25), 215 (+11.11), 219 (+10.24), 231 (+20.50), 
247 (‒19.08), 287 (+0.97), 304 (‒10.16), 325 (+4.11), 333 (+2.13), 347 (‒0.75), 361 (+2.25), 400 (+0.05) nm; 
ORD (MeOH, c 0.2) λmax (log ε in cm2 mol−1) 198 (‒5.03), 208 (‒3.00), 218 (+2.01), 223 (+1.46), 239 (+31.68), 
269 (‒4.94), 295 (+5.11), 315 (‒9.53), 341 (‒0.16), 353 (‒2.86), 373 (+0.22), 387 (+0.56), 437 (‒0.46) nm; 1H 
NMR and 13C NMR data in Table 1 (further details see SI); HRESIMS m/z 813.37280 [M + H + O]+ (calcd for 
C49H53N2O9, 813.37511). The molecular formula was C49H52N2O8.
Cyclombandakamine A6 (6). Yellowish amorphous powder; α[ ]D
23 − 20 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 
201 (1.12), 224 (0.72), 232 (0.73), 263 (0.24), 296 (0.15), 315 (0.19), 329 (0.16), 340 (0.15), 350 (0.17), 361 (0.14), 
380 (0.16), 400 (0.06), 420 (0.01) nm; ECD (MeOH, c 0.09) λmax (log ε in cm2 mol−1) 200 (+5.60), 208 (+2.19), 
212 (+2.98), 220 (+1.58), 231 (+5.60), 245 (‒4.76), 280 (‒0.90), 290 (+0.28), 304 (‒1.65), 326 (+1.64), 355 
(‒1.49), 389 (+0.09), 400 (‒0.09) nm; ORD (MeOH, c 0.09) λmax (log ε in cm2 mol−1) 200 (‒1.96), 204 (‒0.15), 209 
(‒0.89), 218 (+0.73), 225 (‒0.61), 238 (+7.76), 254 (‒0.09), 272 (‒0.35), 283 (‒0.90), 296 (+0.69), 315 (‒1.84), 
342 (1.55), 371 (‒0.69), 397 (‒0.09), 443 (‒0.03) nm; 13C NMR data in Table 1 (for further details, see SI); 
HRESIMS m/z 781.34886 [M + H]+ (calcd for C48H49N2O8, 781.348892).
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Cyclombandakamine A7 (7). Yellowish amorphous powder; α[ ]D
23 − 13 (c 0.04, MeOH); UV (MeOH) λmax (log ε) 
201 (1.88), 216 (1.30), 233 (1.52), 257 (0.50), 277 (0.28), 288 (0.285), 295 (0.28), 315 (0.34), 330 (0.24), 340 (0.19), 
390 (0.02) nm; ECD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 200 (+2.23), 210 (+0.41), 212 (+0.49), 220 (‒0.44), 
234 (+4.66), 251 (‒2.99), 286 (+0.29), 304 (‒1.57), 328 (+0.43), 347 (‒0.03), 354 (+0.20), 365 (+0.27), 400 
(‒0.01) nm; ORD (MeOH, c 0.1) λmax (log ε in cm2 mol−1) 201 (+3.13), 211 (‒4.94), 217 (‒2.12), 224 (‒4.44), 240 
(+19.23), 269 (‒3.45), 294 (+3.05), 314 (‒5.00), 340 (+0.02), 355 (‒0.89), 388 (+0.35), 430 (+0.10) nm; 13C NMR 
data in Table 1 (for further details, see SI); HRESIMS m/z 811.35652 [M + H + O]+ (calcd for C49H51N2O9, 
811.35891). The molecular formula [M]+ is C49H50N2O8.
Oxidative degradation. The ruthenium (VIII)-mediated periodate degradation of the cyclom-
bandakamines 1–7, the Mosher-type derivatization of the resulting amino acids using MeOH/HCl and 
R-α-methoxy-α-trifluoromethylacetyl chloride (R-MTPA-Cl, prepared from S-MTPA), and the subsequent 
GC-MSD analysis were carried out as described earlier19 on a GCMS-QP2010 Systems (Shimadzu, Germany).
Computational analysis. The DFT structural geometry optimizations were done using the B3LYP-D3/
def2-TZVP method, with ORCA17,18,26,27. The TDDFT calculations of the ECD spectra were performed as 
described previously16 using ORCA and Gausian0926–28. TDDFT was used for the simulation of the UV and ECD 
spectral data27, and the calculated spectra were compared with the experimental ones using SpecDis24,25.
Biological evaluation. The in vitro antiprotozoal tests were performed on the NF54 (chloroquine-sensitive) 
and K1 (chloroquine- and pyrimethamine-resistant) strains of Plasmodium falciparum, STIB 900 strain of 
Trypanosoma brucei rhodesiense (trypomastigotes), Tulahuen C4 strain of Trypanosoma cruzi (amastigotes), and 
MHOM-ET-67/L82 strain of Leishmania donovani (axenically grown amastigotes) in duplicate. The tested com-
pounds were evaluated together with 9 and 10 for a better comparison of IC50 values. The cytotoxicity on mam-
malian host cells (rat skeletal myoblast L6 cells) were determined according to established protocols29.
References
 1. Bringmann, G. & Pokorny, F. In The Alkaloids Vol. 46 (ed. Cordell, G. A.) 127–271 (Academic Press, 1995).
 2. Li, J. et al. Jozilebomines A and B, naphthylisoquinoline dimers from the Congolese liana Ancistrocladus ileboensis, with antiausterity 
activities against the PANC-1 human pancreatic cancer cell line. J. Nat. Prod. 80, 2807–2817 (2017).
 3. Bringmann, G. et al. HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana 
Ancistrocladus congolensis. Phytochemistry 128, 71–81 (2016).
 4. Li, J. et al. Dioncophyllines C2, D2, and F and related naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus 
ileboensis with potent activities against Plasmodium falciparum and against multiple myeloma and leukemia cell lines. J. Nat. Prod. 
80, 443–458 (2017).
 5. Taylor, C. M., Gereau, R. E. & Walters, G. M. Revision of Ancistrocladus Wall. (Ancistrocladaceae). Ann. Missouri Bot. Gard. 92, 
360–399 (2005).
 6. Bringmann, G., Wohlfarth, M., Rischer, H., Grüne, M. & Schlauer, J. A new biosynthetic pathway to alkaloids in plants: acetogenic 
isoquinolines. Angew. Chem. Int. Ed. 39, 1464–1466 (2000).
 7. Bringmann, G., Irmer, A., Feineis, D., Gulder, T. A. & Fiedler, H. P. Convergence in the biosynthesis of acetogenic natural products 
from plants, fungi, and bacteria. Phytochemistry 70, 1776–1786 (2009).
 8. Bringmann, G. et al. Biosynthesis of naphthylisoquinoline alkaloids: synthesis and incorporation of an advanced 13C2-labeled 
isoquinoline precursor. Tetrahedron 63, 1755–1761 (2007).
 9. Bringmann, G. et al. Mbandakamines A and B, unsymmetrically coupled dimeric naphthylisoquinoline alkaloids, from a Congolese 
Ancistrocladus species. Org. Lett. 15, 2590–2593 (2013).
 10. Bringmann, G. et al. Jozimine A2: the first dimeric Dioncophyllaceae-type naphthylisoquinoline alkaloid, with three chiral axes and 
high antiplasmodial activity. Chem. Eur. J. 19, 916–923 (2013).
 11. Bringmann, G. et al. Phenolic analogs of the N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A, from Ancistrocladus 
cochinchinensis (Ancistrocladaceae), with improved antiprotozoal activities. Phytochemistry 72, 89–93 (2011).
 12. Xu, M. et al. Shuangancistrotectorines A-E, dimeric naphthylisoquinoline alkaloids with three chiral biaryl axes from the Chinese 
plant Ancistrocladus tectorius. Chem. Eur. J. 16, 4206–4216 (2010).
 13. Mammino, L. & Bilonda, M. K. Computational study of naphthylisoquinoline alkaloids with antimalarial activity from 
Dioncophyllaceae and Ancistrodaceae in vacuo. Theor. Chem. Acc. 135, 101 (2016).
 14. Ibrahim, S. R. & Mohamed, G. A. Naphthylisoquinoline alkaloids potential drug leads. Fitoterapia 106, 194–225 (2015).
 15. Turini, F. G. et al. Microsatellites facilitate species delimitation in Congolese Ancistrocladus (Ancistrocladaceae), a genus with 
pharmacologically potent naphthylisoquinoline alkaloids. Taxon 63, 329–341 (2014).
 16. Lombe, B. K. et al. Cyclombandakamines A1 and A2, oxygen-bridged naphthylisoquinoline dimers from a Congolese Ancistrocladus 
liana. Org. Lett. 19, 1342–1345 (2017).
 17. Tshitenge, D. T. et al. Antiplasmodial ealapasamines A-C, ‘mixed’ naphthylisoquinoline dimers from the Central African liana 
Ancistrocladus ealaensis. Sci. Rep. 7, 5767 (2017).
 18. Tshitenge, D. T. et al. Mbandakamine-type naphthylisoquinoline dimers and related alkaloids from the Central African liana 
Ancistrocladus ealaensis with antiparasitic and antileukemic activities. J. Nat. Prod. 81, 918–933 (2018).
 19. Bringmann, G., God, R. & Schäffer, M. An improved degradation procedure for determination of the absolute configuration in 
chiral isoquinoline and β-carboline derivatives. Phytochemistry 43, 1393–1403 (1996).
 20. Bringmann, G. et al. Ancistrolikokine D, a 5,8′-coupled naphthylisoquinoline alkaloid, and related natural products from 
Ancistrocladus likoko. Phytochemistry 62, 631–636 (2003).
 21. Bringmann, G. et al. Cis- and trans-isoshinanolone from Dioncophyllum thollonii: absolute configuration of two ‘known’, wide-
spread natural products. Phytochemistry 51, 693–699 (1999).
 22. Bringmann, G. & Feineis, D. Stress-related polyketide metabolism of Dioncophyllaceae and Ancistrocladaceae. J. Exp. Bot. 52, 
2015–2022 (2001).
 23. Bringmann, G. et al. The synthesis of all possible isomeric 6,8-dioxygenated 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline methyl 
ethers - useful chiral building blocks for naphthylisoquinoline alkaloids. Liebigs Ann. Chem., 877–888 (1993).
 24. Bruhn, T., Schaumlöffel, A., Hemberger, Y. & Bringmann, G. SpecDis: quantifying the comparison of calculated and experimental 
electronic circular dichroism spectra. Chirality 25, 243–249 (2013).
 25. Bruhn, T., Schaumlöffel, A., Hemberger, Y. & Pecitelli, G. SpecDis - A tool to compare calculated and experimental (chir)optical 
spectra, http://specdis-software.jimdo.com (2017).
 26. Neese, F. The ORCA program system. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2, 73–78 (2012).
1 2Scientific RepoRts |          (2019) 9:9812  | https://doi.org/10.1038/s41598-019-46336-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
 27. Pescitelli, G. & Bruhn, T. Good computational practice in the assignment of absolute configurations by TDDFT calculations of ECD 
spectra. Chirality 28, 466–474 (2016).
 28. Hemberger, Y., Zhang, G., Brun, R., Kaiser, M. & Bringmann, G. Highly antiplasmodial non-natural oxidative products of 
dioncophylline A: synthesis, absolute configuration, and conformational stability. Chem. Eur. J. 21, 14507–14518 (2015).
 29. Orhan, I., Sener, B., Kaiser, M., Brun, R. & Tasdemir, D. Inhibitory activity of marine sponge-derived natural products against 
parasitic protozoa. Mar. Drugs 8, 47–58 (2010).
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB 630, “Agents against Infectious 
Diseases”, project A2) and by the German Excellence Initiative to the Graduate School of Life Sciences, University 
of Würzburg (grant to D.T.T.). Generous support from the Else-Kröner-Fresenius-Stiftung is also acknowledged. 
This publication of the manuscript was funded by the DFG and the University of Würzburg within the funding 
programme Open Access Publishing. The authors thank Mrs. M. Michel for the degradation experiments, and 
Mr. B.K. Lombe for the collection of additional leaf material of A. ealaensis in the Eala Park (Province Équateur, 
DR Congo). Further thank is due to Dr. M. Grüne and Mrs. Altenberger for the 600 MHz NMR support, and to 
Mrs. J. Adelmann for the HRESIMS analyses.
Author Contributions
G.B. and D.F. designed this project. D.T.T. performed the isolation and structural elucidation experiments. 
T.B. performed the TDDFT calculations. G.B., D.T.T. and D.F. jointly wrote the manuscript. V.M. collected 
and validated the plant material used for the isolation of the cyclombandakamines. R.B. and M.K. tested the 
compounds for their antiparasitic activities and evaluated the results. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-46336-z.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
